The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1377
Correction: A Fixed-Dose Combination of Ibuprofen and Famotidine (Duexis)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

In the clinical studies section (Med Lett Drugs Ther 2011; 53:85), the overall incidence of endoscopic gastroduodenal ulcers should have been 11% with Duexis and 21.9% with ibuprofen alone and, in low dose aspirin users, 12.8% with Duexis and 32.8% with ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Correction: A Fixed-Dose Combination of Ibuprofen and Famotidine (Duexis)
Article code: 1377e
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian